oxaloacetic acid and fluorodeoxyglucose f18

oxaloacetic acid has been researched along with fluorodeoxyglucose f18 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anderson, H; Becker, A; Bothwell, R; Brooks, W; Burns, JM; Choi, IY; Clutton, J; Harris, RA; Lee, P; Mahnken, JD; Mosconi, L; Pleen, J; Reed, G; Sherry, E; Swerdlow, RH; Vidoni, ED; Wilkins, HM; Zhang, N	1

Trials

1 trial(s) available for oxaloacetic acid and fluorodeoxyglucose f18

Article	Year
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Dose-Response Relationship, Drug; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Glutathione; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Oxaloacetic Acid; Positron-Emission Tomography; Radiopharmaceuticals	2021

Article

Year

Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.

Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:1

Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognition; Dose-Response Relationship, Drug; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Glutathione; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Oxaloacetic Acid; Positron-Emission Tomography; Radiopharmaceuticals

2021